Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Class II major histocompatibility complex (MHC II) is normally silenced in plasma/multiple myeloma (MM) cells at the transcriptional level through downregulation of class II transactivator (CIITA), allowing MM cells to escape from immunological responses. Here we demonstrate that a retinoic acid receptor-α/β-selective retinoid Am80 (tamibarotene) could induce the expression of functional MHC II molecules in human MM cell lines. Am80 upregulated expression of the interferon regulatory factor-1 gene, followed by enhancement of CIITA expression. This is the first report demonstrating that retinoid can induce the expression of MHC II in terminally-differentiated plasma/MM cells. ©2007 Ferrata Storti Foundation.

Author supplied keywords

Cite

CITATION STYLE

APA

Sanda, T., Iida, S., Kayukawa, S., & Ueda, R. (2007). Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid. Haematologica, 92(1), 115–120. https://doi.org/10.3324/haematol.10300

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free